Dr. Klei is currently a member of Macromolecular Crystallography Department at Bristol-Myers Squibb. Over the past nine years, he has worked on many Structure Based Drug Design projects. In addition to Drug Discovery, his other responsibilities include the integration of crystallization robotics and the coordination of an internal gene-to-crystal database effort termed ASPECT for Automated System for Protein Expression and Crystallization Technology. Before joining Bristol-Myers Squibb, he co-founded K-tec Laboratories which was awarded several DOD research contracts on liquid crystals. Prior to his venture, as an officer in the U.S. Air Force, he worked at the F.J. Seiler Research Laboratory on the Computational Chemistry and Molten Salt Battery projects. He received his BS in Mathematical Sciences from the U.S. Air Force Academy, MS in Chemical Engineering from the University of Washington, and Ph.D. in Biophysics from the University of Connecticut, and MBA in Pharmaceutical-Chemical Studies from Fairleigh-Dickinson University.